Advertisement
Sigma-Aldrich
Sigma-Aldrich

The Scientist

» cancer and immunology

Most Recent

image: Influential Cancer Biologist Dies

Influential Cancer Biologist Dies

By | August 24, 2015

Chris Marshall, who pieced together a critical signaling pathway involved in cancer, has passed away at age 66.

0 Comments

image: Double-Edged Enzyme

Double-Edged Enzyme

By | August 13, 2015

Researchers find evidence to suggest why an enzyme crucial for fighting off malaria infection is linked to a form of lymphoma.

0 Comments

image: Esteemed Cancer Surgeon Dies

Esteemed Cancer Surgeon Dies

By | August 12, 2015

Carolyn Kaelin, a breast cancer surgeon, survivor, and advocate has passed away at age 54.

0 Comments

image: Rethinking Lymphatic Development

Rethinking Lymphatic Development

By | August 1, 2015

Four studies identify alternative origins for cells of the developing lymphatic system, challenging the long-standing view that they all come from veins.

1 Comment

image: The Human Touch

The Human Touch

By | August 1, 2015

Can mice with humanlike tissues better model drug effects in people?

0 Comments

image: The Spleen Collectors

The Spleen Collectors

By | August 1, 2015

Donated organs are helping researchers map out the immune system in humans.

0 Comments

image: Yun “Nancy” Huang: Eager for Epigenetics

Yun “Nancy” Huang: Eager for Epigenetics

By | August 1, 2015

Assistant Professor, Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston. Age: 35

0 Comments

image: Resveratrol’s Low-Dose Anticancer Effect

Resveratrol’s Low-Dose Anticancer Effect

By | July 31, 2015

The antioxidant found in red wine and some berries shows that small doses have more potent antitumor effects than large doses in a mouse model.

0 Comments

image: NK Cell Diversity and Viral Risk

NK Cell Diversity and Viral Risk

By | July 22, 2015

A small study links the diversity of a person’s natural killer cell repertoire to risk of HIV infection following exposure to the virus.

0 Comments

image: Biotech Buys Autoimmune Firm for $7B

Biotech Buys Autoimmune Firm for $7B

By | July 16, 2015

Celgene has purchased Receptos, developer of an experimental multiple sclerosis drug.

0 Comments

Advertisement
Arbor Assays
Arbor Assays

Popular Now

  1. The Mycobiome
    Features The Mycobiome

    The largely overlooked resident fungal community plays a critical role in human health and disease.

  2. Antibody Alternatives
    Features Antibody Alternatives

    Nucleic acid aptamers and protein scaffolds could change the way researchers study biological processes and treat disease.

  3. Circadian Clock and Aging
    Daily News Circadian Clock and Aging

    Whether a critical circadian clock gene is deleted before or after birth impacts the observed aging-related effects in mice.

  4. Holding Their Ground
    Features Holding Their Ground

    To protect the global food supply, scientists want to understand—and enhance—plants’ natural resistance to pathogens.

Advertisement
Advertisement
Life Technologies